CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -69.8% | 13,406 | -54.7% | 0.00% | -50.0% |
| Q2 2022 | $53,000 | +17.8% | 29,592 | +76.4% | 0.00% | 0.0% |
| Q4 2021 | $45,000 | -80.8% | 16,779 | -58.4% | 0.00% | -86.7% |
| Q2 2021 | $234,000 | +51.9% | 40,300 | +52.1% | 0.02% | +114.3% |
| Q3 2020 | $154,000 | -74.3% | 26,500 | -70.1% | 0.01% | -76.7% |
| Q2 2020 | $599,000 | +439.6% | 88,700 | +406.2% | 0.03% | +275.0% |
| Q1 2020 | $111,000 | -1.8% | 17,522 | +62.2% | 0.01% | +60.0% |
| Q4 2019 | $113,000 | -35.4% | 10,800 | -75.8% | 0.01% | -44.4% |
| Q3 2019 | $175,000 | -21.5% | 44,600 | +198.0% | 0.01% | -25.0% |
| Q2 2019 | $223,000 | – | 14,966 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |